We are live on ! Find out more
PC

PA Capital Portfolio holdings

AUM $142M
1-Year Est. Return 46.45%
This Fund
S&P 500
This Quarter Est. Return
+12.71%
1 Year Est. Return
+46.45%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$113M
AUM Growth
+$11.5M
Cap. Flow
+$1.41M
Cap. Flow %
1.25%
Top 10 Hldgs %
27.44%
Holding
161
New
40
Increased
31
Reduced
45
Closed
32

Top Buys

Rank Stock Value
1
RNST icon
Renasant Corp
RNST
+$6.49M
2
BCML icon
BayCom
BCML
+$3.78M
3
VCTR icon
Victory Capital Holdings
VCTR
+$1.45M
4
OSW icon
OneSpaWorld
OSW
+$1.1M
5
BCC icon
Boise Cascade
BCC
+$1.01M

Sector Composition

Rank Sector Weight
1 Technology 22.85%
2 Financials 18.08%
3 Communication Services 16.02%
4 Healthcare 14.61%
5 Consumer Discretionary 10.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GCP
101
DELISTED
GCP Applied Technologies Inc.
GCP
$312K 0.28%
13,759
-11,008
-44% -$237K
NVST icon
102
Envista
NVST
$4.44B
$310K 0.27%
+10,448
New +$297K
RRGB icon
103
Red Robin
RRGB
$145M
$286K 0.25%
+8,660
New +$256K
BX icon
104
Blackstone
BX
$102B
$281K 0.25%
+5,022
New +$261K
PSNL icon
105
Personalis
PSNL
$1.35B
$273K 0.24%
+25,079
New +$261K
CLR
106
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$260K 0.23%
+7,586
New +$235K
ANAB icon
107
AnaptysBio
ANAB
$1.58B
$236K 0.21%
+14,520
New +$343K
CSGP icon
108
CoStar Group
CSGP
$11.7B
$236K 0.21%
3,940
-6,040
-61% -$353K
LSCC icon
109
Lattice Semiconductor
LSCC
$17.6B
$235K 0.21%
12,300
-23,354
-66% -$448K
EXFO
110
DELISTED
EXFO INC.
EXFO
$231K 0.2%
50,000
IMVT icon
111
Immunovant
IMVT
$7.93B
$220K 0.19%
+13,871
New +$155K
NOK icon
112
Nokia
NOK
$51B
$215K 0.19%
+58,000
New +$228K
OSPN icon
113
OneSpan
OSPN
$574M
$188K 0.17%
11,000
ORGO icon
114
Organogenesis Holdings
ORGO
$305M
$184K 0.16%
+38,203
New +$242K
EOLS icon
115
Evolus
EOLS
$385M
$178K 0.16%
+14,629
New +$206K
MAXR
116
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$172K 0.15%
+11,000
New +$114K
GYRE icon
117
Gyre Therapeutics
GYRE
$641M
$166K 0.15%
3,257
-1,322
-29% -$55.4K
SBBP
118
DELISTED
Strongbridge Biopharma plc.
SBBP
$163K 0.14%
77,799
-75,178
-49% -$144K
RCM
119
DELISTED
R1 RCM Inc. Common Stock
RCM
$160K 0.14%
12,340
-12,761
-51% -$146K
EVH icon
120
Evolent Health
EVH
$348M
$156K 0.14%
+17,251
New +$140K
MOBL
121
DELISTED
MobileIron, Inc.
MOBL
$146K 0.13%
29,953
-52,692
-64% -$281K
ADT icon
122
CALL
ADT
ADT
$5.58B
$131K 0.12%
16,600
PRTK
123
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$113K 0.1%
+28,051
New +$97.3K
SWBI icon
124
CALL
Smith & Wesson
SWBI
$651M
$109K 0.1%
15,222
SWBI icon
125
Smith & Wesson
SWBI
$651M
$101K 0.09%
14,207
-47,765
-77% -$291K

Similar funds

PA Capital's Q4 2019 Portfolio in Review

As of Q4 2019, PA Capital held 161 positions worth $113M, up 11% from $102M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

PA Capital's Q4 2019 filing shows 40 new, 31 increased, 45 reduced and 32 closed positions. Its largest new stake was Renasant Corp: 183,964 shares worth $6.52M. The largest sale was BlueLinx, an estimated $6.09M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 26% a quarter earlier, followed by Financials and Communication Services.

  • PA Capital's largest Q4 2019 buy was Renasant Corp: 183,964 shares worth $6.52M.
  • PA Capital added most to OneSpaWorld in Q4 2019, an estimated $1.1M increase.
  • PA Capital's biggest Q4 2019 reduction was UnitedHealth, cutting an estimated $958K.
  • PA Capital fully exited BlueLinx in Q4 2019, selling an estimated $6.09M.
  • PA Capital's ten largest holdings make up 27% of its $113M portfolio in Q4 2019.
  • PA Capital opened 40 new positions and closed 32 in Q4 2019.
  • PA Capital's portfolio value rose 11% quarter-over-quarter to $113M.

Based on PA Capital's 13F filing for Q4 2019, filed 3 Feb 2020.